Daniel C. Brennan, M.D., joins the Johns Hopkins Division of Renal Medicine as professor of nephrology and medical director of the Comprehensive Transplant Center. Dr. Brennan’s areas of clinical expertise include transplant nephrology and renal disease. Prior to joining Johns Hopkins, Dr. Brennan was the Alan A. and Edith L. Wolff Professor of renal Diseases at Washington University and the Director of Transplant Nephrology at the Washington University School of Medicine. He received his undergraduate degree from Cornell College and earned his medical degree at the University of Iowa, where he completed a residency in internal medicine. He then completed research and clinical nephrology fellowships at Brigham & Women’s Hospital/Harvard Medical School. Dr. Brennan holds professional memberships at various organizations, including the American College of Physicians, the International Society of Nephrology, the American Society of Nephrology, The Transplantation Society, the American Society of Transplant Physicians and the American Society of Clinical Investigation. Dr. Brennan is rated as an Elite provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Chronic Kidney Disease, Cytomegalovirus Infection, Cytomegalic Inclusion Disease, Kidney Transplant, and Pancreas Transplant.

Steve Sozio is a Nephrologist in Baltimore, Maryland. Dr. Sozio is rated as an Elite provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Renovascular Hypertension, and Kidney Transplant.

Dr. Crews is a Professor of Medicine in the Division of Nephrology at the Johns Hopkins University School of Medicine. She holds faculty appointments with the School of Nursing, the Welch Center for Prevention, Epidemiology and Clinical Research, the Center on Aging and Health, and the Center for Health Equity, where she is Deputy Director. Her research program aims to advance equity in kidney disease and hypertension outcomes by focusing on social drivers of health inequities. An elected member of the American Society for Clinical Investigation, Dr. Crews has received numerous awards for her research contributions, including the 2018 Johns Hopkins University President’s Frontier Award--a $250,000 award granted to a single faculty scholar on the cusp of transforming their field. She is a former National Academy of Medicine (NAM) Emerging Leader Scholar and was the inaugural Gilbert S. Omenn Anniversary Fellow of the NAM. In 2019, Dr. Crews received the W. Lester Henry Award for Diversity and Access to Care from the American College of Physicians and the Distinguished Leader Award from the American Society of Nephrology. Dr. Crews is the founding director of the Doctoral Diversity Program, a 2-year, research-intensive post-baccalaureate program of the Johns Hopkins Initiative for Careers in Science and Medicine. Dr. Crews received her undergraduate degree from the University of Virginia and her medical degree from Saint Louis University. A graduate of the Osler Medical Training Program, she completed nephrology fellowship and a master’s in clinical epidemiology degree at Johns Hopkins. Dr. Crews is rated as an Elite provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Arteriovenous Malformation, Kidney Transplant, and Nephrectomy.

Matthew Weir is a Nephrologist in Baltimore, Maryland. Dr. Weir is rated as an Elite provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are High Potassium Level, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Kidney Transplant, and Nephrectomy. Dr. Weir is currently accepting new patients.

Dr. Bernard Jaar is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in epidemiology at the Johns Hopkins Bloomberg School of Public Health. His areas of clinical expertise include chronic kidney disease and all dialysis modalities. Dr. Jaar earned his M.D. from Faculte de Medecine et de Pharmacie of the State University of Haiti. He completed nephrology training at Hopitaux de Paris (Hopital Tenon, Hopital Saint Antoine, Hopital Saint Louis) University of Paris V, France. He subsequently completed an internal medicine residency at Graduate Hospital in Philadelphia and a nephrology fellowship at the Johns Hopkins Hospital, in addition to a post-doctoral fellowship in Epidemiology and a Master in Public Health at the Johns Hopkins Bloomberg School of Public Health. His research interests include epidemiology of chronic kidney disease and end-stage kidney disease, particularly survival in dialysis patients, peripheral arterial disease and environmental risk factors for kidney disease. Dr. Jaar was recognized with the C. Lockard Conley Award 2021 by the American College of Physician Maryland Chapter for contributions to resident education / research and the National Kidney Foundation Garabed Eknoyan Award 2022 for promoting the mission of NKF in making the lives of people with kidney disease better. He is a member of several professional organizations, including the International Society of Nephrology, American Society of Nephrology, National Kidney Foundation, American College of Physicians and the International Society of Peritoneal dialysis. Dr. Jaar is rated as an Elite provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Calcinosis, Low Potassium Level, and Kidney Transplant.

Michelle Estrella is a Nephrologist in Baltimore, Maryland. Dr. Estrella is rated as an Elite provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Focal Segmental Glomerulosclerosis, Prerenal Azotemia, and Kidney Transplant.

Rulan Parekh is a Nephrologist and a Pediatrics provider in Baltimore, Maryland. Dr. Parekh is rated as an Elite provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Nephrotic Syndrome, Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Focal Segmental Glomerulosclerosis, and Kidney Transplant.

Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center. Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers. His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease. Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology. Dr. Parikh is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Interstitial Nephritis, Acute Tubular Necrosis, Prerenal Azotemia, Kidney Transplant, and Nephrectomy.

Mohamed G. Atta, MD, MPH, is Professor of Medicine at Johns Hopkins University School of Medicine in Baltimore, Maryland and Director of Von Hippel Lindau Clinical Care Center at Hopkins. A graduate of Mansoura University School of Medicine in Egypt, he completed his internship and residency training in various locations including the Urology and Nephrology Center at Mansoura University, Cabrini Medical Center in New York, and Johns Hopkins University School of Medicine. Dr. Atta received his MPH degree from Johns Hopkins Bloomberg School of Public Health in 2005. Dr. Atta is a member of the Health Disparity Committee at the Department of Health and Mental Hygiene in Maryland, the Scientific Council on Kidney of the American Heart Association, the International Society of Nephrology, and the American Society of Nephrology. Dr. Atta has participated as principal investigator in several studies, clinical trials, and serves as a peer reviewer for the Journal of Clinical Investigation, Archives of Internal Medicine, American Journal of Medicine, Kidney International, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Diseases, Clinical Infectious Disease, and Journal of Infectious Diseases among others. He authored or co-authored numerous articles published in Genomics, the Journal of Biological Chemistry, Journal of clinical investigation, Clinical Infectious Disease, Circulation, Stem Cells Translational Medicine, American Journal of Medicine, and American Journal of Transplantation, Journal of the American Society of Nephrology, Clinical Journal of the American Society of Nephrology, American Journal of Kidney Disease, Nephrology Dialysis Transplantation, and Kidney International, among others. Dr. Atta is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Glomerulonephritis, Lupus Nephritis, Chronic Kidney Disease, and Kidney Transplant.

Dr. C. John Sperati is an Associate Professor of Medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include renal medicine. Dr. Sperati is Director of the Glomerular Diseases Fellowship Program since 2023 and formerly directed the Nephrology Fellowship Training Program from 2019 - 2025. He was the long-serving Firm Faculty Leader of the Barker Firm and has held leadership positions within the Osler Medical Residency training program. In addition, he co-directs the Johns Hopkins Osler Learning Initiative which brings the principles of medical residency training to executive education worldwide. He obtained his medical degree from The Pennsylvania State University College of Medicine and a Master in Health Science from the Johns Hopkins Bloomberg School of Public Health. He completed an internship and residency in Internal Medicine at the Johns Hopkins Hospital, followed by a year as an Assistant Chief of Service (chief resident). He subsequently pursued subspecialty training in nephrology at the Johns Hopkins Hospital and joined the faculty in the Division of Nephrology. Dr. Sperati’s clinical interests are in thrombotic microangiopathy including atypical hemolytic uremic syndrome (aHUS), complement-mediated kidney diseases including C3 glomerulopathy, glomerular disease such as glomerulonephritis (e.g., IgA nephropathy, MPGN) and nephrotic syndromes (e.g., FSGS, membranous, minimal change, amyloidosis, and others), and secondary and resistant hypertension (e.g., fibromuscular dysplasia, atherosclerotic renal arterial disease, hyperaldosteronism, and genetic hypertensive syndromes). He is the site principal investigator for clinical trials in glomerular disease, serves on editorial boards, and chairs the approval committee of the Longitudinal Knowledge Assessment for nephrology for the American Board of Internal Medicine. His clinical acumen and educational contributions have been recognized by induction into the Miller Coulson Academy of Clinical Excellence as well as the American Society of Nephrology Distinguished Educator Award in 2020. He has been recognized as a physician resource through the Atypical HUS Foundation, a NephCure glomerular disease specialist, an IgA Nephropathy Foundation specialist, and a Baltimore TopDoc. He is registered with the Florida Department of Health to perform telehealth services for patients in Florida. Dr. Sperati is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Atypical Hemolytic Uremic Syndrome (aHUS), D-Plus Hemolytic Uremic Syndrome, Hemolytic-Uremic Syndrome, Glomerulonephritis, and Kidney Transplant.

Eric Brown is a Nephrologist in Owings Mills, Maryland. Dr. Brown is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Acute Kidney Failure. Dr. Brown is currently accepting new patients.

Jeffrey Posner is a Nephrologist in Owings Mills, Maryland. Dr. Posner is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease. Dr. Posner is currently accepting new patients.

Sonal Korgaonkar is a Nephrologist in Owings Mills, Maryland. Dr. Korgaonkar is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, Chronic Kidney Disease, and End-Stage Renal Disease (ESRD). Dr. Korgaonkar is currently accepting new patients.

Anita Pasumarthy is a Nephrologist in Baltimore, Maryland. Dr. Pasumarthy is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Nephrosclerosis, Renovascular Hypertension, End-Stage Renal Disease (ESRD), and Chronic Kidney Disease.

Dr. Luis F. Gimenez is an assistant professor of medicine at the Johns Hopkins University School of Medicine. His area of clinical expertise includes nephrology. Dr. Gimenez received his medical degree from Facultad de Medicina de la Universidad de Chile. He completed residencies in internal medicine at Hospital Clinico Regional Dr. Guillermo Grant Benavente, Hospital Carlos Van Buren and the Johns Hopkins School of Medicine. He performed his fellowship in nephrology at Johns Hopkins. His research interests include the pathophysiology of chronic renal failure. Dr. Gimenez is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Minimal Change Disease.

Dr. Derek M. Fine is an associate professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include glomerular kidney disease, particularly lupus nephritis and other immune-mediated kidney diseases, HIV-related kidney disease, scleroderma-related kidney disease, acute kidney injury, hyponatremia, kidney biopsy, and rhabdomyolysis. Dr. Fine earned his M.D. at Johns Hopkins. He completed his residency in internal medicine and his fellowship in nephrology at Johns Hopkins. His research interests include HIV-related kidney diseases and lupus nephritis. He is a member of the Miller Coulson Academy of Clinical Excellence and was named 2018 Physician of the Year at Johns Hopkins Hospital. Dr. Fine is rated as a Distinguished provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Lupus Nephritis, Glomerulonephritis, Systemic Lupus Erythematosus (SLE), Chronic Kidney Disease, and Kidney Transplant.

Dr. Samir Gautam, is an Assistant Professional of Medicine at Johns Hopkins School of Medicine with expertise in Nephrology and Critical Care Medicine. He staffs patients in Johns Hopkins Hospital, chronic dialysis clinics, Bayview Medical Center and clinic and also has a specialty clinic Post AKI clinic at Johns Hopkins Outpatient Center. Dr. Gautam is rated as an Advanced provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Acute Kidney Failure, and Nephrosclerosis.

Dr. Rebecca Ruebner is an Associate Professor of Pediatrics at the Johns Hopkins University School of Medicine. She provides care for children with kidney problems of any type including hypertension, hematuria, proteinuria, kidney stones, chronic kidney disease, dialysis, and kidney transplant. She is the medical director of pediatric dialysis. Dr. Ruebner received her undergraduate and medical degrees from the University of Pennsylvania. She completed her residency at Boston Children’s Hospital where she also served as chief pediatric resident. She completed her fellowship in pediatric nephrology at the Children’s Hospital of Philadelphia. During her fellowship, she received a Master's Degree in Clinical Epidemiology from the University of Pennsylvania. Dr. Ruebner became a faculty member at the Children's Hospital of Philadelphia in 2012 before joining the Johns Hopkins faculty in 2016. Dr. Ruebner's clinical research is focused on clinical care and outcomes of children with chronic kidney disease and end-stage kidney disease. Dr. Ruebner is rated as an Advanced provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are End-Stage Renal Disease (ESRD), Chronic Kidney Disease, Hemolytic-Uremic Syndrome, D-Plus Hemolytic Uremic Syndrome, and Kidney Transplant.

Dr. Meredith Atkinson is an associate professor of pediatrics in the Johns Hopkins University School of Medicine. She provides care for children with kidney problems of any type, including patients on dialysis; patients with proteinuria, hematuria and chronic kidney disease; and kidney transplant. Dr. Atkinson's clinical research interests focus on chronic kidney disease and end-stage kidney disease in children. Her specific interests include mechanisms and treatment of anemia in chronic kidney disease and racial disparities in patient outcomes. She is the recipient of numerous research grants and awards, including a K23 Patient Oriented Research award from the National Institute of Diabetes and Digestive and Kidney Diseases/NIH, and young investigator grants from the National Kidney Foundation, the National Kidney Foundation of Maryland, the Thrasher Research Fund and Amgen Inc. She is currently the PI of the Renal Anhydramnios Fetal Therapy (RAFT) trial. She received her undergraduate degree in biology from Mount Holyoke College. She earned her M.D. from the University of Rochester School of Medicine and Dentistry. She completed a residency in pediatrics at Johns Hopkins, followed by a fellowship in pediatric nephrology at Hopkins, completed in June 2007. During her fellowship training, Dr. Atkinson received a master’s degree in epidemiology from the Johns Hopkins Bloomberg School of Public Health. Dr. Atkinson joined the Johns Hopkins faculty in 2007. Dr. Atkinson was elected to the Society for Pediatric Research in 2014. She is a member of several professional organizations including the American Society of Nephrology, and is the president of the American Society of Pediatric Nephrology for 2024-2026. Dr. Atkinson is rated as an Advanced provider by MediFind in the treatment of Chronic Kidney Disease. Her top areas of expertise are Potter Syndrome, Lupus Nephritis, Glomerulonephritis, Anemia, and Kidney Transplant.

Dr. Edward Kraus is a Professor of Medicine in the Department of Medicine, Division of Nephrology, at the Johns Hopkins University School of Medicine. He completed his undergraduate education at Cornell University, received his MD at Northwestern University and completed an Internal Medicine residency at Cleveland Metropolitan General Hospital in Cleveland, OH. After completing a Nephrology Fellowship at Baltimore City Hospitals, Dr. Kraus has been a member of the faculty since 1981. As part of his clinical duties he has cared for kidney transplant patients during his entire tenure at Johns Hopkins. As the scope of the kidney transplant program grew, his clinical responsibilities during the last 15 years have been limited to care of kidney and pancreas transplant donors and recipients. He currently serves as the Senior Kidney Transplant Nephrologist and Medical Director of the Pancreas Transplant Program. Dr. Kraus’ interests have focused upon factors affecting the long-term outcomes of kidney transplant recipients and barriers to access of care for minority recipients. He has worked extensively with Pathology and has participated in the development of the Johns Hopkins Incompatible Kidney Transplant Program with particular emphasis on evolving concepts of patterns of injury with the goal of development of clinical interventions to preserve allograft function. Dr. Kraus is a member of the National Kidney Foundation, the American Society of Nephrology, the International Society of Nephrology and the American Society of Transplantation. He actively serves on Committees of these various organizations. Upon nomination by his patients, students and peers in recognition for his clinical care and teaching skills, Dr. Kraus was inducted into the Miller-Coulson Academy of Clinical Excellence at the Johns Hopkins Bayview Medical Center. Dr. Kraus is rated as an Advanced provider by MediFind in the treatment of Chronic Kidney Disease. His top areas of expertise are Chronic Kidney Disease, End-Stage Renal Disease (ESRD), Cytomegalic Inclusion Disease, Kidney Transplant, and Splenectomy.